课题基金 / 基金详情

CTSA INFRASTRUCTURE FOR AIDS RESEARCH

CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
批准号:
8365156
负责人:
GARY S FIRESTEIN
金额:
$35.68万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2012-03-31

项目摘要

项目成果

GARY S FIRESTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
本分项目是CTSA供资的估计百分比,即 被用于广泛的研究领域(艾滋病研究、儿科研究或 临床试验)。列出的总成本仅是对CTSA金额的估计 用于这一研究领域的基础设施,而不是由 授予子项目或子项目工作人员的NCRR补助金。 我们已经建立了圣地亚哥临床和转化研究所(圣地亚哥CTRI),其中心设在加州大学圣地亚哥分校(UCSD)。该区域中心包括两所大学(UCSD和圣地亚哥州立大学),4个生物医学研究所(Salk Inst.,Burnham Inst.,J.Craig Venter Inst.和La Jolla Inst,过敏和免疫学),3家学术医院(UCSD医学中心,VA医院和Rady儿童医院),1个社区卫生中心/ICE(Palomar Pomrado Health)和2个专业资源-圣地亚哥超级计算机中心和加利福尼亚Inst,用于电信和信息技术。CTSA项目包括3个健康科学专业学校(医学、药学、护理),9个临床研究博士项目,以及一个高级临床研究硕士项目。该计划的目标是:1)为临床和转化科学学科提供学术基础;2)建立一个综合教育渠道,以培训和支持临床和转化科学家;3)开发强大的临床研究基础设施,以综合研究取代孤岛;4)增强利用加州大学圣迭戈分校独特资源的生物信息学能力;5)开发新技术,以改进研究,如生物标记物和成像;6)与研究机构和行业形成翻译研究联盟;7)与社区医生和普通公众建立社区联盟,将科学发现转化为最佳实践,增加医疗保健差距的研究,并让普通公众参与生物医学科学。CTSA计划将提供资源,以发展临床和转译研究学科。通过圣地亚哥CTRI,将加强培训下一代临床和转化型科学家的教育渠道。一个新的K12计划,一个扩展的K30计划,以及在临床研究中整合新的博士研究生计划,都突出了拟议的教育计划。CTRI将通过协调不同的项目,提供从高中到博士后学生的广泛教育,并为博士后研究员和教师提供培训,来改变临床和转化科学的教育。该研究所还将通过提供从初始规划到数据分析和共享的指导和支持,来改变临床研究的进行。新架构将促进新技术的发展,以促进临床研究,并为开展临床研究所需的服务和资源提供支持。我们将特别强调几个优势领域,如成像、生物标记物、社区推广,以及将基础科学发现转化为临床科学。相关性(参见说明):圣地亚哥临床转化研究所将通过提供从初始规划到数据分析和共享的指导和支持来改变临床研究。它将提供培训下一代临床和转化型科学家的教育渠道,并让社区参与制定本组织的方向和优先事项。该研究所将促进促进临床研究的新技术的开发,并为开展临床研究和改善健康所需的服务提供支持。
英文摘要
This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. We have established the San Diego Clinical and Translational Research Institute (San Diego CTRI), with its hub located at the University of California, San Diego (UCSD). This regional center contains two universities (UCSD and San Diego State University), 4 biomedical research institutes (Salk Inst., Burnham Inst., J. Craig Venter Inst., and La Jolla Inst, for Allergy and Immunology), and 3 academic hospitals (UCSD Medical Center, VA Hospital and Rady Children's Hospital), one community health sen/ice (Palomar Pomerado Health) and 2 specialized resources~the San Diego Supercomputer Center and the California Inst, for Telecommunications and Information Technology. The CTSA program encompasses 3 health sciences professional schools (Medicine, Pharmacy, Nursing), nine clinical research PhD programs, and a Masters program in Advanced Clinical Studies. The program goals are to: 1) Provide an academic home for the discipline of clinical and translational science; 2) Establish an integrated educational pipeline to train and support clinical and translational scientists; 3) Develop a robust clinical research infrastructure that replaces silos with integrated research; 4) Enhance bioinformatics capabilities that leverage unique UCSD resources; 5) Develop novel technologies to improve research such as biomarker and imaging; 6) Form a Translational Research Alliance with research institutes and industry; 7) Form a Community Alliance with community physicians and the general public to translate scientific discoveries into best practices, increase research into health care disparities, and involve the general public in biomedical science. The CTSA program will provide the resources to develop the discipline of clinical and translational research. Through the San Diego CTRI, the educational pipeline to train the next generation of clinical and translational scientists will be enhanced. A new K12 program, an expanded K30 program, and the integration of new PhD graduate programs in clinical research highlight the proposed educational plan. The CTRI will transform education in clinical and translational science by coordinating disparate programs, providing breadth of education from high school through pre-doctoral students and providing training to post-doctoral fellows and faculty. The Institute will also transform the conduct of clinical research by providing guidance and support from initial planning through data analysis and sharing. The new structure will foster development of novel technologies to facilitate clinical research and provide support for the services and resources necessary to conduct clinical investigation. We will place special emphasis on several areas of strength such as imaging, biomarkers, community outreach, and the translation of basic science discoveries to clinical science. RELEVANCE (See instructions): The San Diego Clinical Translational Research Institute will transform the clinical research by providing guidance and support from initial planning through data analysis and sharing. It will provide an educational pipeline to train the next generation of clinical and translational scientists and involve the community in setting the direction and priorities of the organization. The Institute will foster development of novel technologies that facilitate clinical research, and provide support for the services needed to conduct clinical investigation and improve health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenic role of ILC2 in rheumatoid arthritis
Pathogenic role of ILC2 in rheumatoid arthritis
Joint Bioinformatics and Computational Core of the MARC
Joint Bioinformatics and Computational Core of the MARC
海外基金